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DRVS for early vitrectomy in VH PDR (1985)
§ Early VH, VA <5/200, >1 month are eligible for early pars 
plana vitrectomy (PPV) (in 1-6 months) or conventional 
(until macula detach or unclear vitreous >1 year)
• After 2 yrs, good vision gain 25% in early PPV, 15% in 
conventional
• Type I DM has better outcome than type II
• Approximately 20% of these worsened to no light perception after 
PPV 
• Delayed PPV in type II is not recommended
§ Improvements in PPV techniques such as endolaser, C3F8 
injection, better microscopeviewing systems, and earlier 
vitrectomy
• only 3% progressed to poor visual outcome (Mason AJO 2005) 
PPV for VH PDR : Indications
§ Visually significant, non clearing hemorrhage
§ Tractional RD involving or threatening macula
§ Combined Tractional-Rhegmatogen RD




§ Difficult to do fibrovascular membrane dissection 
(delamination or segmentation)
§ Postoperative vitreous hemorrhage (VH)  
TIPS
Laser prior to PPV as much as possible (needs clear media, 
take 2-3 weeks until BV regressed, facilitate MP)
Avoid inflamed eye, risk of fragile retina (iatrogenic break, 
unreleased traction, etc) : PRP

Anti VEGF injection
§ Regressed blood vessel (no need clear media, 
short effect)
§ Anti-inflammatory (swelling, inflamed 
vitreous/retina, etc)
PROs
§ To decrease intraoperative hemorrhage 
§ Facilitate fibrovascular membrane dissection, easier 
separation of FVM from the underlying retina
§ Reduce postoperative vitreous hemorrhage (VH) rates
debateful…
Meta-analysis IVB Pre PPV
Zhao LQ, BJO 2016
Zhao LQ, BJO 2016
IVB Pre PPV versus PPV Alone
§ Incidence of intraoperative bleeding and frequency of 
endodiathermy  p<0.01
§ Less surgical time than the control group (p=0.003). 
§ Shorter reabsorption time of blood (p=0.04)
§ Incidence of recurrent VH (p=0.05)
§ Better final best-corrected visual acuity (p=0.003)
§ Other complications, including final retinal detachment, 
and reoperation, were statistically insignificant
Zhao LQ, BJO 2016
§ The surgical endpoint was the relief of traction on 
the macula and areas of TRD and a clear vitreous 
cavity.
§ Dose IVB 1.25 mg 2-4 days before PPV
• early incidences of recurrent VH (<1 week) eligible for PPV
• Can be detected in the retinal tissue 14 days after intravitreal 
injection (Chen, Retina 2006)
• 7-day with 20-day previtrectomy IVB gave similar clinical 
outcome but more difficult surgery in 20-day group
• Cikini Hospital : 2.5 mg/0.1 ml + 0.1 ml Dexa 1-10 days before 
PPV
IVB Pre, Durante, Postop ?
PROs and CONs
PROs 
§ To decrease intraoperative hemorrhage and 
§ Facilitate fibrovascular membrane dissection
§ Reduce postoperative vitreous hemorrhage (VH) 
rates
CONs
§ Concern still exists that IVB may worsen TRD 
§ May cause the foveal vascular zone enlargement
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